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IMPORTANCE Congenital hypotrichosis with juvenile macular dystrophy (HJMD) is a rare
disorder presenting in childhood and adolescence with central visual disturbance and sparse
scalp hair. Reported retinal imaging is lacking, and whether the condition is progressive
remains unclear.
OBJECTIVE To investigate a series of patients with HJMD due to biallelic mutations in CDH3
and thereby characterize the disorder.
DESIGN, SETTING, AND PARTICIPANTS Ten patients from 10 families underwent detailed
clinical assessment, including serial retinal imaging and electrophysiologic evaluation, at
Moorfields Eye Hospital, St James’s University Hospital, and Calderdale Royal Infirmary.
Patients ranged in age from 3 to 17 years at onset and 5 to 57 years at last assessment. The
molecular genetic investigation included bidirectional Sanger sequencing of all exons and
intron-exon boundaries of CDH3 and whole-exome sequencing in 2 patients. The study was
conducted from June 5, 2013, to January 15, 2016, with final follow-up completed on
December 15, 2015.
MAIN OUTCOMES ANDMEASURES Results of clinical assessment andmolecular genetic
testing.
RESULTS All 10 patients (7 male and 3 female) presented with central visual disturbance in
childhood and had lifelong sparse scalp hair with normal facial hair. Fundus examination
revealed chorioretinal atrophy of the posterior pole contiguous with the disc in all but 1
patient that was associated with marked loss of autofluorescence on fundus
autofluorescence imaging. Optical coherence tomography (OCT) demonstrated variable
degrees of atrophy of the outer retina, retinal pigment epithelium, and choroid, with outer
retinal tubulations frequently observed. One patient hadmild disruption of the inner segment
ellipsoid band on OCT and additional mild digit abnormalities. Electrophysiologic evaluation
in 5 patients demonstratedmacular dysfunction with additional mild, generalized retinal
dysfunction in 2 patients. Eight patients hadmore than 1 evaluation; of these, 5 patients
showed deterioration of visual acuity over time, 1 patient remained stable, and 2 patients had
severe visual loss at presentation that precluded assessment of visual deterioration. The area
of atrophy did not progress with time, but retinal thickness decreased on OCT.
Electrophysiologic evaluation in 1 patient found deterioration of macular function after 13
years of follow-up, but themild, generalized photoreceptor dysfunction remained stable.
Biallelic mutations were identified in all patients, including 6 novel mutations.
CONCLUSIONS AND RELEVANCE These results suggest that CDH3-related disease is
characterized by a childhood-onset, progressive chorioretinal atrophy confined to the
posterior pole. The disease is readily distinguished from other juvenile macular dystrophies by
the universally thin and sparse scalp hair. Patients may have additional limb abnormalities.
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F irst described in 2 brothers in 1935, congenital hypotri-chosis with juvenile macular dystrophy (HJMD [OMIM601553]) presents in childhood with central visual loss
andassociatedabnormalityof thescalphair.1CongenitalHJMD
is a rare, recessively inherited disorder reported to date in a
total of 21 familieswithmolecular confirmation and 15 differ-
ent causativemutations.2-12 The disease is caused by biallelic
loss of function mutations in the CDH3 gene (OMIM 114021),
which encodes P-cadherin, a regulator of hair, retinal pig-
ment epithelium (RPE), and limb development.2,7 Ectoder-
mal dysplasia, ectrodactyly, and macular dystrophy syn-
drome (EEMS [OMIM 225280]) constitute an allelic disorder
also associated with biallelic CDH3 mutations.13 The pheno-
type for EEMS is variable, with macular dystrophy; ectoder-
mal involvement that includes hypotrichosis, nail dysplasia,
and partial anodontia; and limb defects that include syndac-
tyly (joineddigits), campylodactyly (bent digits), or ectrodac-
tyly (missing phalanges that, when most severe, has a claw-
handappearance).Only6familieswithmolecularconfirmation
have been reported in the literature, with 5 additional patho-
genic mutations in CDH3 identified.6,7,13,14
Apart from a series of 7 families that focused on electro-
physiologic findings, the previous descriptions of CDH3-
relatedmaculardystrophycontain limited retinal imagingand
electrophysiologic data.15,16 This study reports the results of
detailed phenotyping, including serial imaging and electro-
physiologic evaluation, in 10 patients with biallelic CDH3
mutations and describes 6 novel mutations.
Methods
Clinical Assessment
Patients for this study were ascertained fromMoorfields Eye
Hospital (London, England), St James’s University Hospital
(Leeds, England), and Calderdale Royal Infirmary (Halifax,
England) from June 5, 2013, to January 15, 2016. The study
protocol adhered to the tenets of the Declaration of
Helsinki17 and received approval from the local ethics com-
mittees. Written informed consent was obtained from all
participants or parents of children before their inclusion in
this study.
Each patient underwent a full clinical examination, in-
cluding visual acuity (VA) and dilated fundus examination.
Retinal fundus imagingwasobtainedby35° color funduspho-
tography (Topcon Great Britain Ltd), 30° or 55° fundus auto-
fluorescence (FAF) imaging (Spectralis; Heidelberg Engineer-
ingLtd), andoptical coherencetomography(OCT) (Stratus [Carl
ZeissMeditec Inc] or Spectralis). Serial imagingwas available
for 9 eyes of 5 patients (patients 3, 5, 7, 8, and 10). The thick-
ness of the Early Treatment Diabetic Retinopathy Study cen-
tral subfield region was measured using an automated view-
ing module (Heidleberg Spectralis viewing module, version
6.3.4.0), with the RPE basement membrane and the internal
limiting membrane layers checked for accuracy in each OCT
section and manually corrected if necessary. The size of the
atrophic regionwasmapped for each FAF image, with the re-
gion first highlighted using Adobe Photoshop Elements (ver-
sion 14; Adobe Systems Incorporated) and the area then cal-
culatedusingcolor-measuringmacros (ThresholdColorplug-in
in Image J; National Institutes of Health). We assessed only
those images in which the atrophic region border could be
clearlydelineated,whichwaspossible forpatients5and7.Full-
field andpattern electroretinography (ERGandPERG, respec-
tively) were obtained in 5 patients using gold foil electrodes,
which incorporated the International Society forClinical Elec-
trophysiology of Vision standards, with electro-oculography
(EOG) studies performed in 2 patients.18,19
Molecular Biological Assessment
Patient 3 had results of a previousmolecular evaluation avail-
able from elsewhere.4 Patient 1 had undergone targeted-
capture, next-generation sequencing of amacular dystrophy
genepanelconsistingofABCA4,BEST1,C1QTNF5,CDH3,CLN3,
CNGB3,CRB1,ELOVL4,FSCN2, IMPG1,PROM1,PRPH2,RDH12,
RP1L1, RPGR, TIMP3, and TTLL5 (Centre for Genomics and
Transcriptomics).20 Patients 3 and 8 underwent whole-
exomesequencing,with Sanger sequencing confirmation and
family segregation subsequently performed. Whole-exome
sequencing was performed at AROS Applied Biotechnology
using a solution-phase 38-Mb exome capture (SureSelect
Human All Exon Kit; Agilent Technologies Inc) and a se-
quencer (HiSeq2000; Illumina Inc). Readswere aligned to the
hg19humanreferencesequenceusingNovoalign (version2.05;
Novocraft). TheANNOVAR tool (Openbioinformatics.org)was
used to annotate single-nucleotide polymorphisms and small
insertions and deletions.
The mutations in the remaining patients were identified
by Sanger sequencing of all exons and exon-intron boundar-
ies of CDH3. We amplified DNA using specifically designed
primers by polymerase chain reaction, and the resulting
fragments were sequenced using standard protocols (eTable
1 in the Supplement). Segregationwas performed in available
family members.
Mutation nomenclature was assigned in accordance with
GenBankNM_001793.4withnucleotideposition 1 correspond-
ing to the A of the ATG translation initiation codon.We identi-
fied variants as novel if not previously reported in the litera-
ture and if absent from dbSNP (http://www.ncbi.nlm.nih.gov
/projects/SNP/); the National Heart, Lung, and Blood Institute
GO Exome Sequencing Project (https://esp.gs.washington.edu
Key Points
Question What can a detailed phenotyping study of molecularly
characterized patients with CDH3-relatedmacular dystrophy
reveal about the disease presentation and progression?
Findings This case series of 10 patients identified universal
childhood-onset thin scalp hair in conjunction with predominant
macular dysfunction. The retinal dystrophy appeared to be
centrally progressive with preserved peripheral retinal function.
Meaning These data suggest that children presenting with
macular dystrophy can be diagnosed as having CDH3-related
disease based on examination of the scalp. The likely prognosis
indicates preservation of peripheral vision.
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/drupal/); the1000GenomesProject (http://www.1000genomes
.org/); and the Exome Aggregation Consortium (http://exac
.broadinstitute.org), all accessedonJanuary25,2016.The likely
pathogenicity of missense variants was assessed using the
predictivealgorithmsofSIFT(Sorting IntolerantFromTolerant)
(http://sift.jcvi.org)andPolyPhen2(http://genetics.bwh.harvard
.edu/pph2); the conservation of the residues throughout the
species was analyzed using Clustal Omega (http://www.ebi.ac
.uk/Tools/msa/clustalo/)withidentificationofproteinsequences
fromEnsembl (http://ensembl.org/index.html).Final follow-up
was completed onDecember 15, 2015, and datawere analyzed
fromOctober 30, 2015, to January 25, 2016.
Results
Ten patients (7 male and 3 female) from 10 families under-
went investigation. Eight families were consanguineous
(Figure 1). The clinical data are summarized in the Table.
Most of the patients presented in the first decade of life with
reduced central vision; the oldest presentation was at 17
years of age. Visual acuity was reduced in all patients at pre-
sentation, and at last review, deterioration was documented
in 5 patients (range of review, 1-8 years). Themean age at last
review was 27.2 (median, 24.5; range, 5-57) years, with VA
ranging from 0.18 logMAR (Snellen, 20/30) to hand move-
ments. The oldest patients had a VA of 1.0 logMAR (Snellen,
20/200) or worse in their better-seeing eye, indicating
severe sight impairment. The best VA was in patient 7, with
0.18 logMAR (Snellen, 20/30) OU at age 31 years. Four
patients reported subjective deterioration of central vision.
Only patient 4 reported nyctalopia. Nystagmus was not
reported in any patient.
Fundus abnormalities consisted of variable degrees of
atrophy of the retina, RPE, and choroid in the posterior
pole, which in all but the youngest patient extended nasally
to the disc (Figure 2 and eFigure 1 in the Supplement). The
atrophy in 7 patients extended outside the arcades. Patient 1
had very mild macular atrophy of the outer retina only,
whereas patients 9 and 10 had severe chorioretinal atrophy
with exposed sclera. Variable degrees of hyperpigmented
spots or clumps in the macula were evident in all patients.
Serial imaging (available in 5 patients) demonstrated
increasing hyperpigmentation over time in 3 patients (dem-
onstrated in Figure 2 for patient 7). Fundus autofluoresence
imaging demonstrated confluent hypoautofluorescence in
areas of atrophy with a surrounding ring of relatively
increased autofluorescence in 6 of the 7 patients with FAF
results available. A speckled hypoautofluorescence was
present within the area of confluent atrophy in patients 5
and 8 (Figure 2). Patient 7 had small refractile deposits in
both maculae.
Figure 1. Pedigrees of 10 FamiliesWithMutation Segregation
Family 4, Jordan
M: c.1508G>A
(p.Arg503His)
M/M
Family 5, Turkish Cypriot
M: c.830delG
(p.Gly277Alafs*20)
M/Ma
Family 7, Portugal
M: c.830delG
(p.Gly277Alafs*20)
M/M
Family 6, Portugal
M: c.613G>A (p.Val205Met)
novel
M/M
Family 1, White German
M1: c.316_317delAA (p.Lys106Glufs*12)
M2: c.1086G>A (p.Trp362*)
both novel
M1/WT WT/M2
M1/M2
Family 3, Lahore, Pakistan
M: c.1568delA
(p.Asn523Metfs*14)
novel
M/WT
M/M M/WT M/WT
Family 2, Punjab, Pakistan
M: c.1425-1G>T
M1/WT WT/M2
WT/M M/WT
M/M
Family 8, Punjab, Pakistan
M: c.2357delG (p.Gly786Alafs*7)
novel
M/M M/WT
Family 9, Lahore, Pakistan
M: c.2157C>T (p.Arg720*)
novel
WT/M
M/M
M/M
Family 10, White English
M: c.160 + 1G>A
M/M
Circles represent female individuals;
squares, male individuals; filled
symbols, affected; hollow symbols,
unaffected; double line,
consanguinity; and small arrow,
affected proband. M indicates
mutation allele; WT, wild-type allele.
a Sequencing result from Indelman
et al.4
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In the 9 patients with OCT results available, variable
degrees of atrophy were noted. In patient 1, only mild dis-
turbance of the inner segment ellipsoid band was observed;
patient 10 showed extensive atrophy of the retina, RPE, and
choroid in addition to a serous retinal detachment over the
atrophic area in the left eye (Figure 2). In the remaining 7
patients, outer retinal and RPE atrophy was present, with
partial preservation of the inner segment ellipsoid band at
the fovea in patient 7. Seven patients had outer retinal tubu-
lations, and patient 5 in addition had intraretinal cysts in
the outer nuclear layer. The overall size of the atrophic
region did not appear to increase with time based on mea-
surements in 2 patients only. However, retinal thickness
within the atrophic region decreased with time in all 5
patients undergoing measurement for 2 to 10 years (eFigure
2 in the Supplement).
Electrophysiologic evaluation demonstrated undetect-
able PERG in 3 of the 5 patients with test results, consistent
with severe macular dysfunction (Figure 3 and eFigure 3 in
the Supplement). A subnormal PERG P50 component was
found in patient 3 at age 14 years in keeping with moderate
macular dysfunction. In patient 7, the PERG was markedly
subnormal at age 18 years and was undetectable at examina-
tion 9 years later (Figure 3). Bilateral full-field ERG abnor-
malities were present in patients 4 and 7, indicating mild,
generalized rod and cone dysfunction (Figure 3). Marginal
reductions were found in the rod-mediated ERGs in the
right eye of patient 5 and rod and cone ERGs in the left eye
of patient 8, but these were likely consequent on eye clo-
sure. The full-field ERGs in patient 7 showed no significant
change at retesting after 9 years. Patients 3 and 5 underwent
EOG studies with normal findings.
Systemically, all patients had thin scalp hair from at least
early childhood, with normal hair elsewhere, including eye-
brows (eFigure 4 in the Supplement). Patient 1 hadmildweb-
bing between the second and third digits of his left hand and
campylodactyly of his feet, most apparent in the second
digits of each foot. All other patients had normal limbs.
Molecular genetic testing identified biallelic muta-
tions in CDH3 in all 10 patients, including 5 novel premature
Table. Clinical Summary
Patient No./
Family No./Variant
Age, y VA, logMAR (Snellen)
Latest Refractive
Error, D
Color Vision
(Age, y)
Age at Last
Electrophysiologic
Evaluation, y/
Key FindingsOnset
At Last
Review
(Duration) Presenting Final
Patient
1/NA/c.316_317delAA
(p.Lys106Glufs*12) and
c.1086G>A (p.Trp362*)
3-4 5 (1) OU, 0.32 (20/40) OU,
0.63 (20/80)
OD,
+8.50/−2.25 × 112
OS,
+9.00/−1.75 × 70
Not performed Not performed
Patient 2/NA/c.1425-1G>T 6 11 (2) OD, 0.5 (20/63)
OS, 0.8 (20/125)
OD, 0.6 (20/80)
OS, CF
Not performed Ishihara
OU, 1/17 (10)
Not performed
Patient 3/GC18250/
c.1568delA
(p.Asn523Metfs*14)
11 19 (6) OU, 0.4 (20/50) OD,
0.80 (20/125)
OS, CF
OD,
0/−2.50 × 177
OS,
−0.25/−2.25 × 162
Ishihara
OD, 5/17
OS, 6/17 (13)
14/ Subnormal PERG
P50
Normal ERGs
Normal EOG
Patient 4/GC19726/
c.1508G>A(p.Arg503His)
4-5 20 (0) OD, 1.0 (20/200)
OS, 1.2 (20/320)
NA Not performed Ishihara
OU, 1/17 (20)
20/Undetectable PERG
Subnormal rod and
subnormal and mildly
delayed cone ERGs
Patient 5/GC20690/
c.830delG
(p.Gly277Alafs*20)
5-6 24 (8) OU, 0.30 (20/40) OD,
0.80 (20/125)
OS,
0.30 (20/40)
OD,
+0.50/−2.00 × 5
OS, emmetropic
HRR
Medium
red/green
defect,
blue/yellow
normal (22)
22/Undetectable PERG
Mildly subnormal rod
ERGs OD
Other ERGs normal OU
Normal EOG
Patient 6/GC22774/
c.613G>A/(p.Val205Met)
4 25 OD, 1.0 (20/200)
OS, 1.2 (20/320)
NA Myopic Ishihara
OD, 3/21
OS, 0/21 (25)
Not performed
Patient 7/GC18293/
c.830delG
(p.Gly277Alafs*20)
8-9 31 (20) OU, 0.18 (20/30) OU,
0.18 (20/30)
OD,
−1.00/−1.00 × 170
OS,
−1.00/−0.50 × 60
Ishihara
OD, 15/17
OS, 12/17 (28)
18/Markedly
subnormal PERG P50
Subnormal rod ERGs
and subnormal and
delayed cone ERGs
27/Undetectable PERG;
stable ERGs
Patient 8/GC19948/
c.2357delG
(p.Gly786Alafs*7)
17 36 (3) OD, 0.6 (20/80)
OS, 1.2 (20/320)
OD,
0.84 (20/125)
OS,
1.20 (20/320)
OD,
−0.50/−0.50 × 40
OS,
+0.50/−2.50 × 180
Ishihara
OU, 1/17 (33)
33/Undetectable PERG
Rod and cone ERGs
normal OD
Marginally subnormal
OS due to eye closure
Patient 9/NA/c.2157C>T
(p.Arg720*)
<10 44 (3) OU, HM OU, HM Not performed Not performed Not performed
Patient
10/GC18996/c.160 + 1G>A
10 57 (7) OU, 1.3 (20/400) OU,
1.20 (20/320)
Not performed HRR
OU, no plates
seen (54)
Not performed
Abbreviations: CF, counting fingers; D, diopter; EOG, electro-oculography; ERG, electroretinogram; HM, handmovements; HRR, Hardy, Rand and Rittler
Pseudoisochromatic Plate test; NA, not applicable; PERG, pattern electroretinogram; VA, visual acuity.
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Figure 2. Retinal Imaging in 6 Patients
Age 56 y
Patient 1, age 5 yA
1 2 3
Patient 10, age 50 yF
1 2 3
Patient 3, age 19 yB
1 2 3
Patient 8, age 34 yE
1 2 3
Patient 5, age 23 yC
1 2 3
Patient 7, age 18 y Age 28 yD
1 2 3
Color fundus photographs (1), fundus autofluorescence (FAF) imaging (2), and
optical coherence tomography (OCT) (3) are shown for each patient. Patient 1
hadmild pigment change on color fundus photography; increased
autofluorescence nasally indicating loss of photoreceptor outer segments on
FAF imaging; and disruption of the inner segment ellipsoid band on OCT. For all
other patients, color fundus photography showed posterior pole atrophy
encompassing the optic disc, most marked in patient 10, with exposed sclera
and hyperpigmented lesions visible in all patients and shown to increase over
time for patient 7. Loss of autofluorescence corresponding to atrophy with
speckled hypoautofluorescent spots are visible in patients 5 and 8 on FAF
imaging. Loss of outer retina and retinal pigment epithelium (RPE) with outer
retinal tubulations was seen on OCT in patients 5, 7, and 8 (yellow arrowhead)
and cystic spaces of the outer nuclear layer in patient 5. Hyperpigmented
lesions correspond to thickened RPE on OCT as demonstrated in patient 5
(yellow arrowheads). Patient 10 has extensive loss of retina, RPE, and choroid
with a serous detachment of remaining retina from underlying residual
choroid/sclera.
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termination codons and 1novelmissensemutation (Figure 1).
The novel missense mutation, c.613G>A (p.Val205Met), was
predicted tobedamaging insilico (SIFT0;PolyPhen21.0).Only
1othermutation,Arg503His,wasamissensemutation thathas
been previously reported in 3 affected families.3,4 Both mis-
sensevariants arise in codons that arehighly conservedacross
species. Patient 1 was a compound heterozygote; all other
patients had homozygote mutations.
Figure 3. Electroretinography Features
DA 0.01 DA 10.0 LA 3.0 30 Hz LA 3.0 PERG
Patient 3, 14 yA
600 μV
400 μV
200 μV
0 V
0 s 100 ms
600 μV
400 μV
200 μV
0 V
0 s 100 ms
200 μV
150 μV
100 μV
50 μV
0 V
0 s 50 ms
200 μV
150 μV
100 μV
50 μV
0 V
0 s 50 ms
4 μV
2 μV
0 V
–4 μV
–2 μV
0 s 100 ms
Patient 5, 22 yB
600 μV
400 μV
200 μV
0 V
0 s 100 ms
600 μV
400 μV
200 μV
0 V
0 s 100 ms
200 μV
150 μV
100 μV
50 μV
0 V
0 s 50 ms
200 μV
150 μV
100 μV
50 μV
0 V
0 s 50 ms
4 μV
2 μV
0 V
–4 μV
–2 μV
0 s 100 ms
Patient 7, 18 yC
600 μV
400 μV
200 μV
0 V
0 s 100 ms
600 μV
400 μV
200 μV
0 V
0 s 100 ms
200 μV
150 μV
100 μV
50 μV
0 V
0 s 50 ms
200 μV
150 μV
100 μV
50 μV
0 V
0 s 50 ms
4 μV
2 μV
0 V
–4 μV
–2 μV
0 s 100 ms
Patient 7, 27 yD
600 μV
400 μV
200 μV
0 V
0 s 100 ms
600 μV
400 μV
200 μV
0 V
0 s 100 ms
200 μV
150 μV
100 μV
50 μV
0 V
0 s 50 ms
200 μV
150 μV
100 μV
50 μV
0 V
0 s 50 ms
4 μV
2 μV
0 V
–4 μV
–2 μV
0 s 100 ms
Normal controlE
600 μV
400 μV
200 μV
0 V
0 s 100 ms
600 μV
400 μV
200 μV
0 V
0 s 100 ms
200 μV
150 μV
100 μV
50 μV
0 V
0 s 50 ms
200 μV
150 μV
100 μV
50 μV
0 V
0 s 50 ms
4 μV
2 μV
0 V
–4 μV
–2 μV
0 s 100 ms
Full-field electroretinogram (ERG) and pattern electroretinogram (PERG)
features are shown for 1 eye of patients 3, 5, and 7 and a normal control.
Patient 3 has normal dark-adapted (DA) ERGs to flash strengths of 0.01 and
10.0 cd/s/m−2 (DA 0.01 and DA 10.0) and normal light-adapted (LA) ERGs to a
flash strength of 3.0 cd/s/m−2 (LA 3.0 30 Hz and 2 Hz); the PERG P50
component is subnormal. Patient 5 showsmild reduction in the right eye DA
ERGs and normal LA ERGs; all left eye responses in that patient were normal. In
all other patients, the ERGs were symmetrically abnormal. The ERG
abnormalities in patient 7 were stable for a 9-year period, but the PERG shows
deterioration of macular function.
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Discussion
This study of CDH3-related retinal dystrophy reports de-
tailedphenotypingofpatientswithmolecularly confirmeddis-
ease and characterizes the key ophthalmic and systemic fea-
tures,whichconfirmthedisorder tobeprogressive.This report
may allow improved recognition of this disorder and provide
more accurate prognostic information for patients.
Thepatientsallpresented inchildhoodoradolescencewith
central visual disturbance, sparse scalp hair, and a predomi-
nantly macular dystrophy. Most of the previously described
patients also presented with reduced VA in childhood except
for 1 family inwhich the eldest childhadnormalVAat 14 years
of age despite visible macular pigmentary change.4
Visual acuity in the present series deteriorated over time,
except in 1 patient with stable and good VA after 20 years of
review and preserved foveal photoreceptors on OCT. Longi-
tudinal data on VA decline have not, to our knowledge, pre-
viouslybeen reported, althoughdecreasedVAwithpatient age
has been observed.15 Patient 1 was unusual within this series
for havingmild structural changes in themacula.Despite this,
VA was significantly reduced, indicating that the function of
themaculawas impairedbefore thedevelopmentof visible at-
rophy.Althoughmost of thepreviously reportedpatients had
markedmacular atrophyencompassing thedisc, 1patientwith
mild atrophic changes and syndactylyl of his left foothasbeen
described.6 The refractile deposits in patient 7 were much
smaller thantheexpectedsizeof refractiledrusen,andnoother
cause couldbeelucidated fromthepatient’smedical history.21
It remainsunclearwhether thesedeposits are related toCDH3
because theyhavenotbeenobservedandreported inanyother
patient.
Detailed retinal imaging has previously been reported in
only 1 patient.16 That 6-year-old patient had typical features
ofposteriorpole atrophywithearly lossofphotoreceptors and
RPE on OCT. In contrast, 7 patients in this study underwent
FAF imagingand9underwentOCT.Apart frompatient 1 in this
series, all patients had marked and confluent hypoautofluo-
rescence on FAF imaging that corresponded to the atrophic
region. This regionwas surrounded by an apparent ring of in-
creased autofluorescence. In general, OCT imaging demon-
strated loss of outer retina andRPEand frequent outer retinal
tubulations. Theposterior pole appears to showatrophy from
early childhood.Thedegreeof atrophywithin that regionpro-
gressedwith time (basedonOCT findings), but theoverall area
of atrophy (basedonFAF imaging) didnot appear to increase,
although this latter observationwas limitedbynumbers avail-
able for analysis.
BilateralERGabnormalitieswerepresent in2of5casesand
were relativelymild, whereasmost had PERG evidence of se-
veremacular dysfunction inkeepingwith the retinal imaging.
The disorder appeared to be largely confined to the posterior
pole. Serial ERGs available in 1 patient demonstrated that the
full-field ERG abnormalities did not progress with time, but
the PERG, a measure of macular function, deteriorated dur-
ing the same 9-year period. The EOG was normal in the 2
patients with test results, consistent with most previous
reports.5,12,16 These previous reports have largely focused on
ERG and EOG findings, with only 1 report of PERG in HJMD.12
That patient had very poor vision at age 48 years, an unde-
tectablePERG, and reducedcone-derivedERGs.TheERGfind-
ings have otherwise been normal or showed subnormal rod
and/or cone responses.2-6,10,12,14-16 One patient was reported
to have severe retinal dysfunction on ERG but without
further details.8
The most common cause of juvenile-onset macular dys-
trophy is Stargardt macular dystrophy due to biallelic muta-
tions in ABCA4 (OMIM 601691).22 That disorder may present
with similar symptoms to CDH3-related disease, with central
visual disturbance, macular atrophy, and electrophysiologic
dysfunction confined to the macula (present in one-third of
children with Stargardt disease) or macular and generalized
retinal dysfunction usually involving cone and rod systems
(found in the other two-thirds).23 Not all patients with Star-
gardtdisease,particularlychildren,have thedistinctiveyellow-
white flecks at presentation. Patients with HJMD may ini-
tially be misdiagnosed with Stargardt disease, but the 2
disorders can be distinguished most readily by examination
of the scalp hair. In addition, the peripapillary region is clas-
sically but not universally spared in ABCA4 retinopathy, and
the macular atrophy observed in children with Stargardt
disease is much less extensive.24
CDH3encodesP-cadherin,amemberof thecadherin trans-
membraneprotein family that formsamajor componentof ad-
herens junctions important in cell-to-cell interactions, includ-
ing cell adhesion, cell signaling, and the formation of other
membrane structures such as desmosomes.25,26 A total of 25
mutations in CDH3 have been reported, including those from
thisstudy—7missenseand2splice-sitemutations—withtherest
beingpremature termination codons (Figure4 andeTable 2 in
the Supplement). All but one of the premature termination
codons identified would be predicted to trigger nonsense-
mediated decay and lead to haploinsufficiency; the excep-
tion,p.G786Afs*7,arisesafter thepredictedcutoff fornonsense-
mediateddecay.27 Patient 8, homozygous for this variant, had
onset of visual symptoms later than all other patients in this
series but otherwise had a similar retinal phenotype. Four of
the7missensevariantswereassociatedwithEEMS,whichmay
indicate that abnormally produced protein has a particularly
detrimental effect on limb development.
P-cadherin regulates the development of hair, limbs, and
the RPE, as demonstrated by upregulation of its expression in
thesekey locations inmouseembryostudies.7 Tissuedevelop-
ment may be controlled by the affinity of tissue-specific
cadherin and their expression levels at certain points in
embryogenesis.28 N-cadherin expression is turned off and
P-cadherin expression is turned on as RPE differentiation
commences.29 P-cadherin is not expressed in the
neuroretina.7,29 This finding suggests that photoreceptor
loss in CDH3-related macular dystrophy is secondary to
P-cadherindysfunction in theRPE.Cadherinproteinsare char-
acterizedbyextracellular, transmembrane,andintracellulardo-
mains (Figure4). The5calcium-bindingextracellulardomains
are critical to protein function by mediating dimerization.30
Reported mutations arise throughout the protein, but all
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reported missense variants are found within the extracellular
domains, which may indicate that their functional impact
is most significant here. The tertiary protein structure for
P-cadherin has been experimentally proven using x-ray
crystallography for extracellular 1 and 2 domains only.30
The site of disease could be primarily RPE with second-
ary photoreceptor loss. Consistent with this possibility, pro-
tein expression in animalmodels has been located toRPEand
not retina.7,29 Inhumans,CDH3messengerRNAhasbeen iden-
tified in expressed sequence tags from RPE.31 Evidence from
theOCTdata in thepresent series suggests that theouter retina
and photoreceptors do not show atrophy before RPE loss, as
would be expected in a primary photoreceptor disorder. The
frequently observed outer retinal tubulations are nonspecific
findings of disorders such as Stargardt disease and age-
relatedmaculardegeneration,whichhaveunderlyingRPEdys-
function with residual photoreceptors forming these charac-
teristic circular structures.32 Normal results of EOG studies in
2 patients suggest that HJMD is not a disorder of primary RPE
dysfunction.
Alternatively, rather than primary RPE dysfunction, the
disorder may be one of concurrent RPE and photoreceptor
loss as occurs in choroideremia, in which outer retinal tubu-
lations are also frequently present.33 Why the retina and RPE
in the posterior pole are particularly predisposed to degen-
eration compared with elsewhere is not clear. The macula is
the region of highest cone density and has a higher meta-
bolic demand than the rest of the retina owing to increased
phototransduction.34 This process necessitates an increased
demand on the RPE for digestion of shed photoreceptor
outer disc membranes, which may be sufficient to compro-
mise the already abnormal RPE cell function andmay lead to
an accumulation of toxic deposits.35 In addition, the Bruch
membrane is thinner in the macula than elsewhere in the
retina, which may increase susceptibility to damage. Further
understanding of CDH3 protein function in the retina and
RPE is ultimately needed to define the location and mecha-
nism of disease.
Although HJMD and EEMS are considered allelic disor-
ders, they may be better considered as part of a phenotypic
spectrum inwhich all patients have hypotrichosis andmacu-
lar dystrophy with variable additional limb and ectodermal
anomalies.14 The same variantmay be associatedwith a vari-
able phenotype. For example, the variant p.G277Afs*20 has
beenassociatedwithHJMDandEEMSin thehomozygousstate
(Figure 3).4,13 Patient 10 in this report, who had no limb or ec-
todermal abnormalities, was found to be homozygous for
c.160 + 1G>A. This variant has been reported once in a com-
pound heterozygous patient in conjunction with a missense
changep.E504K.6 The reportedpatient had syndactyly of left
foot, althoughmild,which suggests anEEMSphenotype.Only
3 other variants have been reported in EEMS, all missense
changes. Reported limb anomalies include severe split hand
or footmalformations,but thesemaybesubtle, suchasa single
nail dysplasia, and should be specifically looked for in
patients presenting with HJMD.7,14
Conclusions
Basedonsymptoms,visual function, retinal imaging, andelec-
trophysiologic characteristics, CDH3-related disease appears
to be centrally progressive with preserved peripheral func-
tion. The characteristic features, with marked macular dys-
function in childhood associated with thin, sparse hair, are
readily recognizable and can aid diagnosis.
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